Vickie and Jack Farber Institute for Neuroscience Jefferson Health

04/02/2026

Highlighting important work from our team!
Proud to see the continued innovation and collaboration advancing stroke care and improving patient outcomes. 🧠💡

ming of antithrombotic initiation in predicting reocclusion among patients who underwent MT with successful recanalization. METHODS: This was a multicenter analysis of patients who underwent successful recanalization from MT at 5 participating institutions across North America between January 2018 a...

03/27/2026

Celebrating a decade of impact and an incredible milestone for our clinical team

We are proud of our team, recognized with the 2026 James B. Erdmann Team Award for Excellence in Interprofessional Collaborative Practice, a distinction which honors clinical teams delivering truly exceptional, person-centered care.

This award reflects the heart of our mission: a collaborative approach where every discipline works together to support patients and families with compassion, expertise, and innovation.

As we mark our 10th anniversary as a center, this honor is especially meaningful. It belongs to every member of our team together with the people living with ALS and their families who inspire us every day.

Here’s to 10 years of collaboration, care, and community, and to many more ahead. 💙




Weinberg ALS Center
Vickie and Jack Farber Institute for Neuroscience Jefferson Health
Jefferson Health
Thomas Jefferson University

03/25/2026

https://www.linkedin.com/posts/jefferson-health_were-proud-to-share-that-john-lauriello-activity-7441483330581188608-zKax?utm_source=li_share&utm_content=feedcontent&utm_medium=g_dt_web&utm_campaign=copy

We’re proud to share that John Lauriello, MD, Daniel Lieberman Professor & Chair, Department of Psychiatry & Human Behavior, Sr. Vice President, Behavioral Health, at Jefferson Health has been named Editor of Focus, the American Psychiatric Association’s clinical review journal. Congratulations,...

03/12/2026

The 25th Annual Cerebrovascular Update is approaching! From March 19-20, 2026, join experts in Philadelphia to advance stroke care through presentations, panel discussions, and innovative strategies. This event is essential for neurologists, neurosurgeons, and healthcare professionals dedicated to improving patient outcomes. Earn up to 8.75 AMA PRA Category 1 Credits.
https://conta.cc/40ZRplP

Email from Jefferson Health System     25th Annual Cerebrovascular Update  Thursday, March 19 - Friday, March 20, 2026 Warwick Hotel Rittenhouse Square | 220 S 17th Street | Philadelphia, PA 19103 Co

03/11/2026

We’re proud to recognize Kelly McLaughlin, PA, in her role as a Functional Advanced Practice Clinician (APC)!

Kelly plays an integral role in supporting patients undergoing complex functional neurosurgical care, helping bridge advanced surgical innovation with compassionate, patient-centered treatment. Her expertise, collaboration with multidisciplinary teams, and commitment to improving outcomes exemplify excellence in Functional Neurosurgery.

Thank you, Kelly, for your continued dedication to advancing care and enhancing the patient experience every day.

03/10/2026

03/09/2026

Did you know that brain surgery for Parkinson's disease or tremors is actually SAFER than many everyday surgeries?

Our neurosurgery team at Jefferson published a new study in Annals of Neurology — and the results might surprise you.

We looked at nearly 3 million surgeries across the country and found that Deep Brain Stimulation (DBS) has:
✅ LOWER complication rates than knee replacement, hip replacement, hysterectomy, and spine surgery
✅ Just about every patient went directly home after the procedure
✅ No higher risk of stroke or neurological injury than any of the comparison surgeries

DBS is a life-changing treatment for people with Parkinson's disease, essential tremor, and epilepsy — but fear of "brain surgery" stops too many people from even asking about it.

The data say: it's time to rethink those fears. 💙

If someone you love has been told DBS might help — please share this with them. And talk to your doctor.

👉 Full study:

Objective Deep brain stimulation (DBS) is an established surgical therapy for movement disorders, epilepsy, and psychiatric conditions, yet remains underutilized due to perceived risks. We therefore...

03/06/2026

Congratulations to Dr. Neva White, recipient of the 2025 Jefferson College of Nursing Distinguished Alumni Award!

Proud to see the incredible impact of her work highlighted in this blog. Through her leadership with the Frazier Family Coalition for Stroke Education and Prevention, stroke education, prevention, and access to care continue to expand across Philadelphia communities.

An inspiring example of how nurse leaders are driving meaningful change in community health. 💙

At Jefferson College of Nursing (JCN), we remain committed to celebrating the transformative power of nurse leadership in advancing health equity. Few embody this more fully than Neva White, DNP, CRNP-BC, CDCES, our 2025 JCN Distinguished Alumni Award recipient, whose visionary work as the Executive...

03/04/2026

🌼 DAISY Award Nominee! 🌼

Shoutout to Kim Krajewski, RN for her extraordinary compassion and presence. She guided a patient and their family through a difficult journey with expert clinical care and a truly heartfelt human connection.

Her kindness and dedication made a lasting impact—earning her a well-deserved nomination for the DAISY Award. 💛

02/24/2026

The Vickie & Jack Farber Institute for Neuroscience at Jefferson Einstein Montgomery Hospital has successfully performed its first pipeline embolization to treat a complex aneurysm near the eye and brain. 🧠

This minimally invasive procedure uses a thin catheter placed through an artery in the wrist or groin to deliver a tiny mesh stent that redirects blood flow away from the weakened vessel. Over time, the aneurysm seals off, helping reduce the risk of rupture, and most patients return home the next day.

We’re proud to bring this highly specialized level of brain and vascular care to Montgomery County!

02/24/2026

Advancing Pituitary Tumor Research
BioPitNeT at Jefferson Health

Learn more at https://biopitnet.uga.edu/

02/16/2026

🧠 Clinical Research Update from Jefferson Neurosurgery

On December 12, 2025, Dr. Chengyuan Wu, in collaboration with Dr. Mijail Serruya, treated the first patient at Jefferson Neurosurgery as part of the Enspire RESTORE DBS Clinical Trial. This investigational research study is evaluating whether Deep Brain Stimulation (DBS) combined with rehabilitation may serve as a possible new treatment approach to improve upper-extremity function in individuals living with chronic stroke-related impairment.

The trial builds on encouraging findings from a Phase I study conducted at Cleveland Clinic, which demonstrated that DBS paired with rehabilitation in 12 patients was feasible and showed promising signals of motor improvement in patients with chronic stroke deficits. RESTORE now aims to further evaluate safety and explore potential effectiveness in a broader cohort. The RESTORE trial is designed to further assess the safety and potential effectiveness of this approach. Participation contributes to ongoing research exploring additional options for stroke recovery.

Learn more about the innovative work behind this effort at enspiredbs.com Enspire DBS Therapy and the RESTORE stroke study.

📩 Interested in more info or joining the study?
Email: neurosurgeryresearch@jefferson.edu
📞 Call: Danna at 610-425-0746

https://neurorestoration.jefferson.edu/programs-clinical-trials/restore.html